Showing results (101-110 of 2,197) with videos related to

Sort By:
Pageof 220
Statistics in Medicine|January 1, 1983
On the standard error of the probability of a particular diagnosisD Machin, N R Dennis, P A Tippett, et al.
The American Journal of Forensic Medicine and Pathology|December 1, 1989
Heart valve measurement at autopsy can distinguish cardiac from non-cardiac causes of deathN Kirkham, S J Peacock, D H Melcher, et al.
The Journal of Hand Surgery, European Volume|April 28, 2009
Flexor pollicis longus tendon ruptures after palmar plate fixation of fractures of the distal radiusJ A Casaletto, D Machin, R Leung, et al.
The West Indian Medical Journal|September 28, 2011
The Jamaican adolescent's perspective on violence and its effectsA Bailey
British Medical Journal (Clinical Research Ed.)|October 1, 1983
Scoring system to improve cost effectiveness of open access endoscopyJ Mann, G Holdstock, M Harman, et al.
British Medical Journal (Clinical Research Ed.)|May 7, 1983
Is the statistical assessment of papers submitted to the "British Medical Journal" effective?M J Gardner, D G Altman, D R Jones, et al.
Statistics in Medicine|April 1, 1985
The use of logit models to investigate social and biological factors in infant mortality. I: MethodologyT J Murrells, T M Smith, J C Catford, et al.
British Journal of Cancer|December 1, 1993
A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working PartyN M Bleehen, D J Girling, D Machin, et al.
Statistics in Medicine|March 1, 1986
The use of logit models to investigate social and biological factors in infant mortality. III. Neonatal mortalityD Machin, T J Murrells, J C Catford, et al.
British Journal of Cancer|December 1, 1993
A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Cancer Working PartyN M Bleehen, D J Girling, D Machin, et al.
Pageof 220